Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus

@article{Morales2017LedipasvirsofosbuvirIE,
  title={Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus},
  author={Amilcar L. Morales and Luz Liriano-Ward and Amber Tierney and Michelle Sang and Alexander Lalos and Mohamed A Hassan and Vinay Nair and Thomas D. Schiano and Rohit Satoskar and Coleman I. Smith},
  journal={Clinical Transplantation},
  year={2017},
  volume={31},
  pages={&NA;}
}
Patients with end-stage renal diseases on hemodialysis have a high prevalence of hepatitis C infection (HCV). In most patients, treatment for HCV is delayed until postrenal transplant. We assessed the effectiveness and tolerance of ledipasvir/sofosbuvir (LDV/SOF) in 32 postkidney transplant patients infected with HCV. The group was composed predominantly of treatment-naïve (75%) African American (68.75%) males (75%) infected with genotype 1a (62.5%). Most patients received a deceased donor… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients

References

Publications referenced by this paper.
SHOWING 1-10 OF 47 REFERENCES

Hepatitis C virus infection and the kidney

  • Meghan E Sise
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2018

AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis

  • AL Morales, L Liriano-Ward, A Tierney
  • C. http://www.hcvguidelines.org2016 Accessed October
  • 2016

Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.

  • Robert J Fontana, Robert S Brown, +27 authors K Rajender Reddy
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2016

Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation.

  • Nassim Kamar, Olivier Marion, +9 authors Laurent Alric
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2016

Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation.

  • Neil E Crittenden, Laura A. Buchanan, +13 authors Matt Cave
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2016

Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents.

  • Deirdre Sawinski, Navpreet Kaur, +6 authors Roy D Bloom
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2016

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.